Maravai LifeSciences Files 8-K: Director/Officer Changes
Ticker: MRVI · Form: 8-K · Filed: Jun 25, 2025 · CIK: 1823239
| Field | Detail |
|---|---|
| Company | Maravai Lifesciences Holdings, Inc. (MRVI) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
TL;DR
Maravai LifeSciences 8-K: Board & exec shakeup, new comp plans.
AI Summary
Maravai LifeSciences Holdings, Inc. filed an 8-K on June 25, 2025, reporting events as of June 22, 2025. The filing covers the departure of directors, election of new directors, appointment of officers, and compensatory arrangements for certain officers. It also includes Regulation FD disclosures and financial statements/exhibits.
Why It Matters
Changes in board composition and executive appointments can signal shifts in company strategy or governance, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with compensatory arrangements, can introduce uncertainty regarding future strategy and leadership stability.
Key Players & Entities
- Maravai LifeSciences Holdings, Inc. (company) — Registrant
- June 22, 2025 (date) — Earliest event reported
- June 25, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific items are covered under the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers' section?
The filing indicates these items are covered, but the specific details of departures, elections, appointments, and compensatory arrangements are not provided in the excerpt.
What is the significance of the 'Regulation FD Disclosure' item?
This indicates that the company is making public disclosures to prevent selective disclosure of material non-public information.
When was Maravai LifeSciences Holdings, Inc. incorporated?
The company was incorporated in Delaware.
What is the principal executive office address for Maravai LifeSciences Holdings, Inc.?
The principal executive office is located at 10770 Wateridge Circle Suite 200, San Diego, California, 92121.
What is the SIC code for Maravai LifeSciences Holdings, Inc.?
The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI).